RD
Robert M Davis
Chairman, CEO & PresidentDirector

Robert M Davis insider trades: Merck (MRK) stock sales

Chairman, CEO & President, Merck Last trade Feb 4, 2026 69 Form 4 filings
$5.6M
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2007
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Robert reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 4, 2026MRK↓ Sell$5.6M
Feb 14, 2024MRK↓ Sell$29.5M
Apr 28, 2023MRK↓ Sell$16.5M
Nov 9, 2022MRK↓ Sell$17.2M
Oct 5, 2020MRK↓ Sell$20.4M
Jun 25, 2019MRK↓ Sell$18.5M
Mar 25, 2019MRK↓ Sell$15.9M
May 17, 2013BAX↓ Sell$9.5M
Jul 25, 2011BAX↓ Sell$6.2M
Dec 14, 2007BAX↓ Sell$1.2M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other MRK insiders

Open-market trades in the last 12 months

About Robert M Davis's insider trades

Robert M Davis is Chairman, CEO & President at Merck (MRK). Since Dec 14, 2007, Robert has reported no open-market purchases and 10 sales worth $140.5M on SEC Form 4. In the last 12 months: 1 sale ($5.6M).

Their filings also include grants and awards (51 filings), shares withheld for taxes (13 filings), option exercises (10 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MRK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.